Lv12
80 积分 2020-05-19 加入
Characteristics and Evolution of Extraintestinal Manifestations Associated with Ulcerative Colitis after Proctocolectomy
5小时前
已完结
Safety and pharmacokinetics of SOR102, an oral bispecific inhibitor of TNF and interleukin-23 in healthy participants and patients with ulcerative colitis: a first-in-human, double-blind, randomised, placebo-controlled, phase 1 trial
1天前
已完结
Gut-Selective Integrin-Targeted Therapies for Inflammatory Bowel Disease
1天前
已完结
The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases
1天前
已完结
P469 Safety, tolerability, and pharmacokinetics of the intestine-restricted oral pan-Janus kinase inhibitor TD-1473 after single and multiple oral doses in healthy subjects
2天前
已完结
Nivolumab for Patients With High-Risk Oral Leukoplakia
15天前
已完结
ABX464 (obefazimod) for moderate-to-severe, active ulcerative colitis: a phase 2b, double-blind, randomised, placebo-controlled induction trial and 48 week, open-label extension
1个月前
已完结
Topical Use of Sucralfate in Epithelial Wound Healing: Clinical Evidence and Molecular Mechanisms of Action
1个月前
已完结
Identification of siRNA silencing TGFβ1 and VEGFR2 and utility of the combination in targeting immune modulation and angiogenesis in treating melanoma in vivo
2个月前
已关闭
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study
2个月前
已完结
皖公网安备34019202002308
